A new approach to diagnosing autism in young children
Official title: Early Diagnostic Response Model (EDRM): Evaluating an Early Screening to Evaluation Pilot Protocol for Children Identified as High Risk for Autism in Early Intervention Health Districts
Run by Emory University · NCT05419895 · Data updated 2026-11-12
This study is testing a new way to diagnose autism in toddlers who are at high risk to see if it can make the process quicker and easier for families.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Months to 36 Months |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Emory University Academic / other |
| Locations | 1 site (Atlanta, Georgia) |
| Status | Recruiting |
| Started | June 16, 2022 |
| Main results expected | July 2028 |
| Study ends | July 2028 |
| Registry record updated | June 10, 2026 |
| Trial ID | NCT05419895 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are families of children aged 16-30 months who have scored 8 or higher on the M-CHAT-R screening and are referred by a participating BCW provider.
✕Probably not a fit
Families whose children are older than 33 months at the time of referral or those making self-referrals will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to develop and evaluate a diagnostic protocol for toddlers at high risk for autism spectrum disorder (ASD) through the Early Diagnostic Response Model (EDRM). Families with children aged 16-30 months who score high on the M-CHAT-R screening will be referred to the Emory Autism Center for assessment. The study will utilize telehealth tools to streamline the evaluation process, addressing the current barriers of limited resources and long wait times for follow-up evaluations. The effectiveness of this model will be assessed through pre- and post-data collection and clinician satisfaction surveys.
Why it matters
Potential benefit: If successful, this approach could significantly improve access to timely autism evaluations for families in need.
How similar studies have gone: While similar telehealth approaches have been explored, this specific protocol for high-risk toddlers is novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All families of children between the ages of 16-30 months of age who scored ≥8 on the MCHAT-R and whose BCW provider refers the child to our clinic by 33 months of age will be a possible participant. Evaluations will be done by 36 months of age. * Referring BCW provider must be one of the participating BCW health districts in this pilot study. * Parent/Guardian needs to have basic English proficiency * Parent/Guardian needs to have internet access * Child must have exposure to English either at home or in out-of-home care (e.g., childcare setting). * Documentation of M-CHAT-R High-Risk failed score (≥ 8) must be documented in referral. Exclusion Criteria: * Families making self-referrals to the EAC or referrals outside of the targeted BCW districts will be excluded from recruitment for this study. * Children above the age of 33 months at the time of the referral will be excluded as the current EDRM protocol has not been developed in this phase of piloting for individuals over this age. * Non-English speakers will be excluded from participation due to the current protocol not being applicable to their needs as well as a high correlation between verbal language abilities and social communication and social interaction (SCI) abilities as part of the DSM-5-TR autism criteria.
Where it's running
-
Emory Autism Center
Atlanta, Georgia, United States Recruiting
Study contacts
- Principal investigator: Allison Schwartz, PhD — Emory University
- Study coordinator: Allison Schwartz, PhD
- Email: allison.schwartz@emory.edu
- Phone: 404.727.8350
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AdiaVita and glutathione for autism in kids and teens
This study tests whether adding AdiaVita (cord-blood stem cells and exosomes) to glutathione helps improve ASD symptoms in children and other participants compared with glutathione alone.
-
Online test of BlinkLab Dx1 for autism in kids aged 2–11
This study tests whether the BlinkLab Dx1 smartphone app can help identify autism in children aged 2 to 11 by comparing app-based measurements with prior clinical diagnoses.
-
Trauma‑Focused Cognitive Behavioral Therapy adapted for autistic children and teens (pilot implementation)
This pilot will try TF‑CBT adapted for autistic children and teens with trauma-related symptoms to see if community mental health clinicians can deliver it and families find it acceptable.
-
CRUSH curriculum for romance and sexual health for autistic young adults
This project will try the CRUSH program—a group course plus one-to-one coaching—to teach sexual health and dating skills to autistic adults ages 18 to 30.
-
Static balance testing in children with autism using a virtual reality system
This project tests whether a virtual reality rehabilitation system can measure static balance differences in children with autism aged 6–10.
-
Do AdiaVita stem cells plus glutathione help kids with autism more than glutathione alone?
This 12-month study tests whether adding AdiaVita stem cells and exosomes to glutathione helps children aged 3–12 with autism more than glutathione alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.